Psilocybin Clinical Trials

Sept 4, 2019

Johns Hopkins launches the Center for Psychedelic and Consciousness Research, focusing on how psychedelics affect behavior, mood, cognition, brain function, learning, memory, and biological markers of health. Resource: The JHU Hub – John Hopkins University

Aug 2017

Research conducted by MAPS on MDMA-Assisted Psychotherapy for PTSD is granted Breakthrough Therapy designation by the FDA. The FDA approves the MAPS protocol for Phase 3 clinical trials. Resource: Multidisciplinary Association for Psychedelic Studies

Aug 14, 2008

The results of research from a team led by Dr. Charles Nichols at the Louisiana State University Health Sciences Center are published in The Journal of Pharmacology and Experimental Therapeutics. Resource: LSU Health New Orleans, School of Medicine